Johnson & Johnson to Acquire Intra-Cellular for $15 Billion
Business And Finance, Finance, Healthcare, Healthcare Policy, Johnson & Johnson, Pharmaceutical

Johnson & Johnson to Acquire Intra-Cellular for $15 Billion

/

Johnson & Johnson acquires Intra-Cellular for $15 billion, strengthening its mental health drug portfolio. Discover the details and impact.